Atea Pharmaceuticals, Inc. (AVIR)

Atea Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	64.7	143.82	188.46	764.38	850.12
Short-Term Investments	390.03	434.28	458.25	-	-
Cash & Short-Term Investments	454.72	578.11	646.71	764.38	850.12
Cash Growth	-21.34%	-10.61%	-15.39%	-10.09%	3824.64%
Accounts Receivable	-	-	-	-	5.82
Other Receivables	-	5.9	-	-	-
Receivables	-	5.9	-	-	5.82
Prepaid Expenses	7.63	6.45	14.21	8.03	7.55
Total Current Assets	462.36	590.46	660.92	772.4	863.48
Property, Plant & Equipment	2.12	3.12	4.09	0.18	0.05
Other Long-Term Assets	0.2	1.4	1.69	0.31	0.11
Total Assets	464.67	594.97	666.71	772.89	863.63
Accounts Payable	4.46	4.25	2.55	4.53	0.06
Accrued Expenses	13.35	27.36	15.11	24.58	14.37
Current Portion of Leases	0.8	0.76	0.72	0.2	-
Current Income Taxes Payable	-	-	0.1	2.57	-
Current Unearned Revenue	-	-	-	-	301.37
Other Current Liabilities	-	-	-	25	-
Total Current Liabilities	18.6	32.38	18.48	56.88	315.8
Long-Term Leases	0.84	1.64	2.4	-	-
Other Long-Term Liabilities	6.36	5.76	5.26	5.93	0.04
Total Liabilities	25.8	39.78	26.14	62.82	315.83
Common Stock	0.08	0.08	0.08	0.08	0.08
Additional Paid-In Capital	802.77	750.74	701.05	653.96	612.88
Retained Earnings	-364.22	-195.84	-59.88	56.03	-65.16
Comprehensive Income & Other	0.23	0.21	-0.68	-	-
Total Common Equity	438.87	555.19	640.57	710.08	547.8
Shareholders' Equity	438.87	555.19	640.57	710.08	547.8
Total Liabilities & Equity	464.67	594.97	666.71	772.89	863.63
Total Debt	1.64	2.4	3.12	0.2	-
Net Cash (Debt)	453.08	575.7	643.59	764.18	850.12
Net Cash Growth	-21.30%	-10.55%	-15.78%	-10.11%	3824.64%
Net Cash Per Share	5.38	6.90	7.73	8.66	39.37
Filing Date Shares Outstanding	85.53	84.16	83.34	83.23	82.74
Total Common Shares Outstanding	84.46	83.44	83.29	83.1	82.44
Working Capital	443.75	558.08	642.44	715.52	547.68
Book Value Per Share	5.20	6.65	7.69	8.54	6.65
Tangible Book Value	438.87	555.19	640.57	710.08	547.8
Tangible Book Value Per Share	5.20	6.65	7.69	8.54	6.65
Machinery	0.5	0.5	0.5	0.06	0.06
Leasehold Improvements	1.48	1.48	1.48	0.13	0.13

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q